Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

Annals of Neurology

Volumn 72, Issue 2, 2012, Pages 234-240

  Mowry, Ellen M ^a   Waubant, Emmanuelle ^a   McCulloch, Charles E ^b   Okuda, Darin T ^c   Evangelista, Alan A ^a   Lincoln, Robin R ^a   Gourraud, Pierre Antoine ^a   Brenneman, Don ^a   Owen, Mary C ^a   Qualley, Pamela ^a   Bucci, Monica ^b,d   Hauser, Stephen L ^a   Pelletier, Daniel ^a,e  

^a UCSF Multiple Sclerosis Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GADOLINIUM;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; RISK FACTOR; SINGLE DRUG DOSE; SMOKING; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BRAIN; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; YOUNG ADULT;

EID: 84865584614     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23591     Document Type: Article

References (29)

1. Hernan MA, Olek MJ, Ascherio A,. Cigarette smoking and incidence of multiple sclerosis. Am J Epiemiol 2001; 154: 69-74. (Pubitemid 32565688)
2. Riise T, Nortvedt MW, Ascherio A,. Smoking is a risk factor for multiple sclerosis. Neurology 2003; 61: 1122-1124. (Pubitemid 37461949)
3. Sundstrom P, Nystrom L, Hallmans G,. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 2008; 15: 579-583. (Pubitemid 351677503)
4. Mikaeloff Y, Caridade G, Tardieu M, Suissa S,; KIDSEP study group. Parental smoking at home and the risk of childhood-onset multiple sclerosis. Brain 2007; 130: 2539-2595.
5. Myhr KM, Riise T, Barrett-Connor E, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998; 64: 539-542. (Pubitemid 28195960)
6. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496-2500. (Pubitemid 40705731)
7. Wandinger KP, Jabs W, Sikehaus A, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55: 178-184. (Pubitemid 30604615)
8. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
9. Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67: 618-624.
10. Simpson S, Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68: 193-203.
11. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
12. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
13. Okuda DT, Srinivasan R, Oksenberg JR, et al. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009; 132: 250-259.
14. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;(2): e1000369.
15. Weinstock-Guttman B, Zivadinov R, Qu J, et al. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2011; 82: 189-195.
16. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164. (Pubitemid 34438881)
17. DiFilippo M, Andersonn VM, Altmann DR, et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2010; 81: 204-208.
18. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817. (Pubitemid 351294716)
19. Sharrack B, Hughes RA, Soudain S, Dunn G,. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141-159. (Pubitemid 29046280)
20. Hobart J, Kalkers N, Barkhof F, et al. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Mult Scler 2004; 10: 41-46. (Pubitemid 38100525)
21. Stewart CA, Horton R, Allcokc RJN, et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 2004; 14: 1176-1187. (Pubitemid 38811554)
22. DiPauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008; 14: 1026-1030.
23. Hernan MA, Jick SS, Logroscino G, et al. Cigarette smoking and the progression of multiple sclerosis. Brain 2005; 128: 1461-1465. (Pubitemid 40826198)
24. Koch M, van Hartern A, Uyttenboogaart M, DeKeyser J,. Cigarette smoking and progression in multiple sclerosis. Neurology 2007; 69: 1515-1520. (Pubitemid 47537858)
25. Healy BC, Ali EN, Guttmann CR, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009; 66: 858-864.
26. Mowry EM, Pesic M, Grimes B, et al. Clinical predictors of early second event in patients with clinically isolated syndrome. J Neurol 2009; 256: 1061-1066.
27. Kang JH, Cook NR, Manson JE, et al. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the women's antioxidant and cardiovascular study. Circulation 2009; 119: 2772-2780.
28. Mei W, Rong Y, Jinming L, et al. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials. Int J Clin Pract 2010; 64: 208-215.
29. Song Y, Cook NR, Albert CM, et al. Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr 2009; 90: 429-437.